Atlas Trials

Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination

Clinical trial NCT01973868 · COMPLETED

Trial details

NCT number
NCT01973868
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2013-11-21
Primary completion
2017-01-31
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.